Xie X - Search Results

1

[Clinical studies in the effect of operative strategies on the hemodynamics in off-pump coronary artery bypass grafting].

Mei J, Wang YQ, Bao CR, Ding FB, Du QR, Xie X, Shen SE. Mei J, et al. Among authors: xie x. Zhonghua Wai Ke Za Zhi. 2008 Feb 15;46(4):241-4. Zhonghua Wai Ke Za Zhi. 2008. PMID: 18683755 Chinese.

2

A novel two-stage complete repair method for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.

Mei J, Ding FB, Zhu JQ, Bao CR, Xie X, Zhang YJ. Mei J, et al. Among authors: xie x. Chin Med J (Engl). 2010 Feb 5;123(3):259-64. Chin Med J (Engl). 2010. PMID: 20193241

3

Modified Nuss procedure in the treatment of recurrent pectus excavatum after open repair.

Guo L, Mei J, Ding F, Zhang F, Li G, Xie X, Hu F, Xiao H. Guo L, et al. Among authors: xie x. Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):258-62. doi: 10.1093/icvts/ivt150. Epub 2013 May 3. Interact Cardiovasc Thorac Surg. 2013. PMID: 23644733 Free PMC article.

4

The role of the ubiquitin-proteasome pathway in cancer development and treatment.

Ding F, Xiao H, Wang M, Xie X, Hu F. Ding F, et al. Among authors: xie x. Front Biosci (Landmark Ed). 2014 Jun 1;19(6):886-95. doi: 10.2741/4254. Front Biosci (Landmark Ed). 2014. PMID: 24896323 Free article. Review.

5

Over-expression of prolyl hydroxylase-1 blocks NF-κB-mediated cyclin D1 expression and proliferation in lung carcinoma cells.

Xie X, Xiao H, Ding F, Zhong H, Zhu J, Ma N, Mei J. Xie X, et al. Cancer Genet. 2014 May;207(5):188-94. doi: 10.1016/j.cancergen.2014.04.008. Epub 2014 May 4. Cancer Genet. 2014. PMID: 24935227

6

USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.

Ding F, Bao C, Tian Y, Xiao H, Wang M, Xie X, Hu F, Mei J. Ding F, et al. Among authors: xie x. Int J Mol Sci. 2014 Dec 25;16(1):307-20. doi: 10.3390/ijms16010307. Int J Mol Sci. 2014. PMID: 25547493 Free PMC article.

7

miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

Xie X, Liu H, Wang M, Ding F, Xiao H, Hu F, Hu R, Mei J. Xie X, et al. Tumour Biol. 2015 Jul;36(7):5031-8. doi: 10.1007/s13277-015-3154-3. Epub 2015 Feb 9. Tumour Biol. 2015. PMID: 25663460

8

LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.

Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS. Xie X, et al. Int J Clin Exp Pathol. 2014 Dec 1;7(12):8881-6. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674259 Free PMC article.

9

USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.

Xiao H, Tian Y, Yang Y, Hu F, Xie X, Mei J, Ding F. Xiao H, et al. Among authors: xie x. Biochem Biophys Res Commun. 2015 May 8;460(3):703-8. doi: 10.1016/j.bbrc.2015.03.093. Epub 2015 Mar 25. Biochem Biophys Res Commun. 2015. PMID: 25817787

10

Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation.

Hu F, Liu H, Xie X, Mei J, Wang M. Hu F, et al. Among authors: xie x. Mol Carcinog. 2016 May;55(5):853-63. doi: 10.1002/mc.22327. Epub 2015 May 6. Mol Carcinog. 2016. PMID: 25945695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,753 results

Search Page

Filters